Neurogene Inc. NGNE
22.93 USD -0.21 (-0.91%)
Regular-session close
23.50 +0.57 +2.49%
After hours · Nov 19, 5:15 PM ET
22.52 Day range 23.36
15.93 52-week range 43.66
- YTD
- +11.31%
- 1 year
- +9.24%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -103.33M | -82.61M | -55.58M | -56.52M | -60.70M | |
| -90.35M | -75.14M | -36.32M | -55.19M | -60.69M | |
| -4.24 | -4.28 | -117.28 | -139.88 | -22.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 104.18M | 136.93M | 148.72M | 82.02M | 142.47M | |
| 288.60M | 335.73M | 222.57M | 109.27M | 163.26M | |
| 23.72M | 25.36M | 36.55M | 10.64M | 20.40M | |
| 9.89M | 12.43M | 14.97M | 4.69M | 12.98M | |
| 264.89M | 310.38M | 186.02M | -145.74M | 142.86M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -77.17M | -70.60M | -51.42M | -52.82M | -47.56M | |
| 14.00M | -125.26M | 25.64M | -2.23M | -3.26M | |
| 30.43M | 184.07M | 92.48M | 66.53M | 732.00K | |
| -1.18M | -808.00K | -321.00K | -2.23M | -3.26M | |
| -32.74M | -11.79M | 66.70M | 11.48M | -50.09M |
